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Abstract 
Background: Sri Lanka has achieved ‘malaria‑free’ status and is now in the phase of prevention of re‑introduction 
of malaria. Imported malaria remains a challenge to resurgence of the disease. The diagnostic challenges encoun‑
tered and the rapid response initiated to manage a Plasmodium infection, which was later confirmed as Plasmodium 
knowlesi, the first reported case from Sri Lanka, is discussed.
Case presentation: An army officer who returned from Malaysia in October 2016 was found to be positive for Plas-
modium both by microscopy and rapid diagnostic test (RDT) by the Anti Malaria Campaign Sri Lanka (AMC) during his 
third visit to a health care provider. Microscopy findings were suspicious of P. knowlesi infection as the smears showed 
parasite stages similar to both Plasmodium malariae and Plasmodium falciparum. Nested PCR at AMC confirmed 
Plasmodium genus, but not the species. In the absence of species confirmation, the patient was treated as a case of 
P. falciparum. The presence of P. knowlesi was later confirmed by a semi‑nested PCR assay performed at the Environ‑
mental Health Institute, National Environmental Agency in Singapore. The parasite strain was also characterized by 
sequencing the circumsporozoite gene. Extensive case investigation including parasitological and entomological 
surveillance was carried out.
Conclusions: Plasmodium knowlesi should be suspected in patients returning from countries in the South Asian 
region where the parasite is prevalent and when blood smear results are inconclusive.
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Background
The World Health Organization (WHO) certified Sri 
Lanka free of malaria in September 2016. As the country 
moves towards the phase of prevention of re-introduc-
tion, imported infections become increasingly significant 
as high densities of the predominant vector, Anopheles 
culicifacies are being reported in most parts of the coun-
try and the population remains at-risk of developing 
malaria [1]. The fact that 221 cases of imported malaria 
have been reported in Sri Lanka between 2013 and 2016 
is important in the context that imported malaria has 
hampered elimination efforts in Zanzibar [2], which is 
progressing towards elimination, and in countries which 
have previously achieved elimination such as Greece and 
Turkmenistan [3, 4].
Since 2008, when a malaria case is reported in Sri 
Lanka, information gathered through rigorous case 
investigation is reviewed thoroughly to exclude any prob-
ability of the case being acquired locally in Sri Lanka. 
Thus far, imported malaria cases that have been reported 
in the country have been due to Plasmodium falciparum, 
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Plasmodium vivax, Plasmodium ovale, and Plasmo-
dium malariae all of which have long been recognized to 
infect humans in nature. This publication discusses the 
diagnostic challenges and case management of the first 
imported case of Plasmodium knowlesi, the fifth species 
of human malaria parasite, reported in Sri Lanka. Plas-
modium knowlesi is primarily a malaria species of non-
human primate origin [5–7].
Following the first case of P. knowlesi reported in 1965 
in an American army personnel who spent five days in a 
primary forest in the northern part of Peninsular Malay-
sia [8], a greater interest was paid to this parasite glob-
ally after a large focus was highlighted from the Kapit 
Division of Sarawak, Malaysian Borneo in 2004 [9]. Since 
then, there have been widespread reports of knowlesi 
malaria from humans [10]. In P. knowlesi infections, high 
parasitaemias can develop rapidly and there is a risk of 
developing severe disease [11, 12].
Results
Patient presentation and investigations
A 31-year old Army Officer who returned on the 31st of 
October 2016 following five months of military training 
in Pulada jungles, Johor Bahru, Malaysia, presented to a 
private medical health care institute in Kandy, situated 
in the Central Province on the 5th of November 2016 
with a 10-day history of fever, chills and rigors, headache 
and arthralgia. The patient was clinically stable at pres-
entation with no significant physical findings other than 
a temperature of 103  °F [°C  =  39.4]. He had not taken 
chemoprophylaxis for malaria.
Fever had developed prior to his departure from 
Malaysia on the 26th of October. Following his return, 
he had taken treatment from two peripheral govern-
ment hospitals where he was managed as having viral 
fever and malaria had not been suspected in the differ-
ential diagnosis. It was after his admission to a private 
hospital in Kandy, 5 days after his arrival, that a consult-
ant physician suspected malaria. The rapid diagnostic 
test (RDT; HRP2/pLDH Combo test) performed at the 
private hospital indicated a positive band for the control 
and pLDH antigen (pan-Plasmodium genus specific). 
Even though the HRP2 band which is specific for P. fal-
ciparum was not seen in the RDT, the blood smear was 
reported as P. falciparum by a trained medical laboratory 
technician. The case was notified to the Regional Malaria 
Officer (RMO) and the Anti Malaria Campaign Sri Lanka 
(AMC) headquarters. Based on the RDT and microscopy 
results of regional and central level public health labora-
tory technicians, and the travel history of the patient, P. 
knowlesi infection was suspected at both laboratories. At 
regional level early and late trophozoites of Plasmodium 
species (parasitaemia 4899 parasites per µl) were seen on 
blood smear examination along with infected red blood 
cells that were not enlarged and no gametocytes were 
seen. In the absence of Schüffner’s stippling, P. vivax and 
P. ovale infections were excluded. On re-examination of 
the smears at the Central Laboratory, which is a reference 
laboratory, the diagnosis of Plasmodium was confirmed. 
The laboratory staff was definite that the species was nei-
ther P. vivax nor P. ovale. The species resembled P. malar-
iae with late band form trophozoites and basket forms, 
but the schizonts were not similar to P. malariae as they 
did not show the characteristic ‘daisy flower’ appear-
ance. The few early trophozoite stages seen, including 
double chromatin stages, were similar to P. falciparum. 
Therefore, it was suspected that the species could be P. 
knowlesi. A genus and species-specific, nested polymer-
ase chain reaction (PCR) assay [13] which was carried 
out at the Central Laboratory for the confirmation of 
diagnosis was positive for genus Plasmodium, while the 
species specific nested PCR was negative for P. falcipa-
rum, P. vivax, P. ovale, and P. malariae.
Initial blood tests revealed a white blood cell count 
of 4.2  K/µl (normal adult reference range 4.00–10.00), 
haemoglobin of 14.2 g/dl (normal reference range 11.0–
16.0), platelets of 162  K/µl (normal ref range 150–450), 
a normal C reactive protein of 0.8 mg/l) and normal urea 
(21.8 mg/dl) and electrolytes.
In the absence of a definitive species diagnosis, consid-
ering the initial microscopy findings and based on WHO 
guidelines for the treatment of a suspected P. knowlesi 
case [14] whereby all suspicious or doubtful cases should 
be treated as P. falciparum, the patient was treated at the 
Teaching Hospital, Kandy as a P. falciparum infection, as 
per national guidelines, with the recommended dose of 
artemether (20  mg)-lumefantrine (120  mg) for a 3-day 
period and a single dose of primaquine (45 mg/kg body 
weight). No side effects were noted. No parasites were 
observed by microscopy and RDT by the third day (8 
November) of treatment. The recovery period was une-
ventful. The patient was discharged with a diagnosis card 
with required dates for parasitological follow-up.
Considering the disease epidemiology of malaria in 
Malaysia, to confirm the diagnosis of P. knowlesi, filter 
paper blood samples were sent to the Environmental 
Health Institute (EHI), National Environment Agency, 
Singapore, a public health laboratory for vector borne 
disease research and a WHO Collaborating Centre for 
Arboviruses and Related Vectors. The specimen was con-
firmed as positive for P. knowlesi by a semi-nested, spe-
cies-specific PCR assay performed at EHI. The parasite 
was genetically characterized by sequencing the circum-
sporozoite (csp) gene. The phylogenetic analysis con-
firmed that the P. knowlesi strain reported in the current 
study was closely related to those reported previously 
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from Peninsular Malaysia (Fig.  1). Therefore, analysis of 
parasite sequence data agreed with the case history that 
indicated a strong likelihood of acquiring the infection in 
Peninsular Malaysia.
Confirmation of P. knowlesi by PCR technology
An in-house designed semi-nested PCR assay was used 
to confirm the presence of P. knowlesi. The first round 
(nest1) of PCR assay amplified the complete csp gene of 
Plasmodium spp. using oligonucleotides PkCSP-F [9] and 
PKCSPR2 [15]. PCR amplification was carried out in a 
50 µl reaction, containing 5 µl of genomic DNA, 1× Phu-
sion® Flash PCR Master Mix (Thermo Fisher, USA) and 
0.5 µM of each primer. The cycling parameters consisted 
of an initial denaturation at 98  °C for 10  s, followed by 
44 cycles of 98 °C for 1 s, 55 °C for 5 s, and extension at 
72 °C for 20 s. The final elongation was at 72 °C for 2 min. 
The first-round PCR assay products were subjected to a 
second round (nest 2) of PCR, using P. knowlesi-specific 
primers CspKnowlesiF (5′-ACCTTGARGTGGAA-
GCTTGTGT-3′) and PKCSPR2 [15]. The second-round 
amplification was carried out in a 20  µl reaction, con-
taining 2 µl of the first-round PCR product as template, 
1× reaction buffer, 2 mM MgCl2, 200 mM of each dNTP, 
1.25 U of GoTaq DNA polymerase (Promega, USA), and 
0.25 µM of each forward and reverse primer. The thermal 
cycling profile for the second-round PCR reaction was as 
follows; initial denaturation at 95 °C for 4 min, followed 
Fig. 1 Phylogenetic analysis of Plasmodium species based on the non‑repeat regions of csp gene. The tree was constructed using the neighbour‑
joining method implemented in MEGA version 6.0 software [17] under the Kimura‑2 parameter model with transition and transversions. Figures on 
the main branches are bootstrap percentages obtained through 1000 replicates. The complete csp gene sequences retrieved from the GenBank 
database are shown in the tree with respective accession numbers, country of origin and the reported period (if available). Plasmodium knowlesi 
sequence of the case reported is marked with a star
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by 44 cycles of 95 °C for 30 s, annealing at 63 °C for 30 s, 
and extension at 72 °C for 30 s. The final elongation was 
at 72 °C for 2 min. All PCR reactions were carried out in 
a Veriti® Thermal Cycler (Applied Biosystems, USA). The 
amplified products of the second-round PCR were visual-
ized in 2% agarose gel stained with GelRed® stain (Bio-
tum Inc, USA).
Cloning and sequencing of the Plasmodium csp gene
The complete csp gene of Plasmodium spp. amplified 
in the first-round PCR was cloned using the NEB® PCR 
Cloning Kit (New England Biolabs, USA), according to 
the manufacturer’s instructions. Fourteen Escherichia coli 
transformants were screened by colony PCR. The colony 
PCR products were purified by using GeneJet® PCR Puri-
fication Kit (Thermo Scientific, USA) according to the 
manufacturer’s protocol. The csp gene was sequenced at 
a commercial sequencing facility by using the Cloning 
Analysis Forward Primer (5′–ACCTGCCAACCAAA-
GCGAGAA-3′) and Cloning Analysis Reverse Primer 
(5′-TCAGGGTTATTGTCTCATGAGCG-3′) provided 
by the cloning kit. Sequencing was carried out according 
to the BigDye Terminator Cycle Sequencing kit (Applied 
Biosystems, USA) protocol.
DNA sequence analysis
The consensus sequence of csp gene was obtained by 
assembling the raw sequencing data using Lasergene 
version 8.0 (DNASTAR, USA). The combined sequence 
encoding the non-repeat regions of N-terminal and 
C-terminal of the csp gene was aligned with the respec-
tive regions of csp gene sequences retrieved from the 
GenBank database using BioEdit version 7.0.9.0 [16]. 
Phylogenetic analysis was performed using the neigh-
bour-joining method implemented in MEGA version 6.0 
software [17]. The Kimura-2 parameter model with tran-
sition and transversion was used in the analysis. Internal 
node reliability was measured by the bootstrap method 
after 1000 replicates.
Entomological and parasitological surveillance and vector 
control
A strenuous operation was mounted to carry out ento-
mological and parasitological surveillance to ensure no 
transmission of the disease takes place. Entomological 
surveillance was commenced by the entomology team of 
the RMO of the district within 24 h of the case diagno-
sis. The patient was a resident of the Hanguranketha area 
in the Nuwara Eliya district where there is a potential for 
onward transmission as the primary vector for human 
malaria species in Sri Lanka, Anopheles culicifacies has 
been reported from the beds of rivers of Mahaweli and 
Uma Oya in this district [18]. As the only vectors known 
to transmit P. knowlesi belong to the Leucophyrus group 
[8, 19], receptivity of the areas surrounding the positive 
case was surveyed to determine the presence and distri-
bution of potential vectors. Considering that Anopheles 
elegans and Anopheles mirans have been incriminated as a 
natural vectors of simian malaria in Sri Lanka [8, 20], and 
it has been shown to breed in the Central Province of the 
country [21], entomological surveillance activities were 
carried out to ensure no vector-borne transmission is tak-
ing place. Entomological techniques carried out included 
indoor hand collection, cattle-baited trap techniques, win-
dow traps, full and partial human landing night catches 
and larval surveys. During this survey, one An. culicifa-
cies larva was encountered in a burrow pit (0.07 larvae per 
100 dips), and An. elegans larvae (0.85 larvae per 100 dips) 
were found breeding in built wells in the areas situated 
within a 1-km radius surrounding the patient’s residence 
in the Nuwara Eliya district, but no adults were encoun-
tered. Entomological surveillance carried out in other 
sites at which the patient had stayed a night during the 
course of illness identified no anophelines.
Initiation of vector control activities took place imme-
diately with the addition of larvivorous fish Poecilia 
reticulata (guppy) to wells, distribution of long lasting 
insecticide treated nets to 132 neighbouring households 
and fogging of the area with an insecticide mixture com-
posed of d-tetramethrin 40  g/l, Cyphenothrin 120  g/l 
(Pesguard) EC to cover approximately 1-km radius of res-
idence of the patient and all destinations he stayed addi-
tional nights.
When an imported malaria case is reported, all indi-
viduals who return with the index case from overseas 
are traced and each individual is tested for malaria. 
This patient had returned alone from Malaysia. In addi-
tion, 125 household members and neighbours of the 
case were screened for malaria by microscopy and RDT 
as part of the reactive case detection, and were negative 
for malaria. To ensure that there is no secondary trans-
mission from the index case, parasitological screening of 
these close contacts was repeated 28 days after the diag-
nosis. In this survey, 152 blood smears were examined 
and all were negative for malaria.
Malaria awareness programmes
A malaria awareness programme was carried out for the 
public in the area where the patient resides to educate the 
community on the need to seek treatment should they 
develop fever. The staff of all government and private 
hospitals and general practitioners in the vicinity were 
contacted to confirm the absence of any patients with 
malaria and to make them aware of the need to carry out 
a diagnostic test for malaria should a patient present with 
fever.
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Follow‑up
As per guidelines of the AMC, the patient was screened 
for malaria by microscopy and RDT on the seventh and 
14th days by a house visit at his residence. On the 21st 
day he reported to AMC headquarters and on the 28th 
and 42nd days he was screened at his work place in a sep-
arate district. The patient was negative for malaria during 
the follow-up period.
Notification
The case was notified to the relevant administrative offic-
ers in the Central Province, and the higher officials of 
the Ministry of Health after confirmation of diagnosis in 
order to further strengthen malaria surveillance by the 
public and private sector health-care institutes.
The case was also notified to the Malaria Advi-
sor, WHO SEARO and Coordinator Malaria and Vec-
tor borne and Parasitic Diseases Unit, WHO Regional 
Office of the Western Pacific. It was also discussed at the 
monthly review meetings of the AMC which are attended 
by all RMOs in the country, technical staff of AMC head-
quarters and representatives of the security forces. Rep-
resentatives of the Sri Lanka Army, were advised to fill 
the gaps regarding prophylaxis to armed forces personnel 
going overseas to malaria endemic-countries.
Discussion
Malaria transmission has been completely interrupted in 
Sri Lanka and locally acquired malaria cases are absent. A 
highly effective malaria surveillance system exists in the 
country, However, in spite of Ministry of Health’s efforts, 
both as a stand-alone organization as well as jointly with 
other medical professional bodies to train and re-train 
practising clinicians on the need to be alert to malaria, 
which remains a formidable challenge in the face of a 
‘forgotten’ disease, this case was missed in the differential 
diagnosis by the two initial peripheral hospitals.
Malaria diagnosis is carried out free of charge in public 
health institutes, and private health care institutions can 
request malaria diagnosis directly either from AMC HQ 
or RMOs free of charge. Once diagnosed as malaria, even 
in the private sector as seen with this case, the case must 
be reported to the AMC. AMC provides anti-malarial 
drugs and guidance on malaria treatment. An immedi-
ate case investigation is initiated by obtaining informa-
tion from each confirmed case to ascertain where and 
how the infection may have been acquired and the risks 
involved in the possibility of onward transmission. Travel 
history, regularity of chemoprophylaxis, patient’s behav-
iour to minimize mosquito contact while overseas and 
dates of all major events in the travel and clinical history 
are recorded both at the regional level and central level 
(AMC headquarters). The main focus of the AMC is to 
ensure that any malaria-positive case reported does not 
contribute towards development of an active focus which 
could be a challenge to the prevention of malaria re-
introduction to Sri Lanka. The rapid response teams are 
mobilized by AMC headquarters and/or RMOs who are 
on constant vigil to carry out foci investigations around 
each positive case, targeted towards preventing second-
ary cases through onward transmission.
Microscopy has remained the gold standard for malaria 
diagnosis in Sri Lanka. Public health laboratory techni-
cians working in over 200 hospital-based centres through-
out the country have been trained by the AMC to carry 
out malaria microscopy free of charge, enabling early 
diagnosis and management of malaria cases. However, it 
is well-established that microscopy alone cannot reliably 
distinguish P. knowlesi from P. malariae and P. falciparum 
due to morphological similarities of the late stages (band 
forms) of P. malariae and P. knowlesi and the early stages 
(ring stages) of P. falciparum and P. knowlesi [22–24]. This 
is most likely the reason for the possible misdiagnosis of 
the case as a P. falciparum infection at the private hospi-
tal. It could be argued that due to the presence of tropho-
zoites and schizonts which are not usually present in a P. 
falciparum infection, this could have been a mixed infec-
tion with P. malariae. Based on the morphology and his-
tory given by the patient, there was doubt at regional level 
and the Central Laboratory of AMC as to whether the 
species could be P. knowlesi. However, as P. knowlesi cases 
have never been reported in the country before, and since 
P. knowlesi and P. malariae cannot be differentiated by 
microscopy alone without molecular diagnostic confirma-
tion, a species confirmation was not given by microscopic 
examination. The RDTs that are used to complement 
microscopic diagnosis of malaria in Sri Lanka can detect 
pan-specific pLDH, but to date no specific RDTs have 
been developed for the diagnosis of P. knowlesi infection 
and existing formats of RDTs are found to perform erro-
neously when used in P. knowlesi-endemic regions [25]. 
Therefore, PCR-based assays are recommended for the 
precise detection of P. knowlesi infections using species-
specific primers [14]. The PCR assay conducted initially 
at the AMC excluded P. falciparum, P. vivax, P. ovale, and 
P. malariae. Given the strong suspicion of a diagnosis of 
P. knowlesi, assistance was sought from EHI, National 
Environmental Agency, Singapore, where the diagno-
sis of P. knowlesi was confirmed. The total duration from 
initial diagnosis of Plasmodium to the confirmation of P. 
knowlesi was 11  days. AMC Central Laboratory is now 
underway to establish the P. knowlesi specific PCR assay 
to advance its diagnostic capabilities.
This patient was managed as a case of P. falciparum 
infection, considering the need to treat for a worst case 
scenario as the laboratory evidence was inconclusive at 
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the time of initiating treatment and also noting the fact 
that P. falciparum is prevalent in Malaysia [26]. The pos-
sible diagnosis of P. knowlesi was also evaluated consid-
ering (a) the high proportion of P. knowlesi infections 
(77.8% of malaria infections) in the Johor Bahru area in 
Malaysia from where this patient arrived [26]; (b) the 
strong suspicion of P. knowlesi based on the morphol-
ogy of the blood smears; (c) the presence of a nested PCR 
positive for Plasmodium species. WHO guidelines [14] 
indicate that all suspicious or doubtful cases of P. knowlesi 
should be treated as P. falciparum and the artemether-
lumefantrine combination used in this patient is highly 
effective for P. knowlesi [12]. Even though chloroquine is 
effective for the treatment of uncomplicated P. knowlesi 
infections, artemisinin based therapies are associated 
with a superior early therapeutic response [12]. In the 
absence of a definitive diagnosis following the comple-
tion of the full course of artemisinin based combination 
therapy, a single dose of primaquine was administered 
to this patient considering it as a possible P. falciparum 
infection. National treatment guidelines as well as WHO 
treatment guidelines [11] recommend using primaquine 
in P. falciparum infections as a measure of reducing 
transmission. However, primaquine is not considered 
necessary for the treatment of P. knowlesi infections in 
endemic regions as it is primarily a zoonosis without evi-
dence of human to human transmission, the sexual stages 
are cleared with the drugs used to treat asexual stages 
and the fact that no hypnozoites are formed [27–29].
This patient was classified as an imported malaria case. 
This finding was further consolidated as: (a) there was 
no infective stages isolated during entomological sur-
veillance; (b) no malaria positives being reported during 
the parasitological screenings; (c) no malaria positives 
reported from General Practitioners and clinicians serv-
ing in the areas where the case was reported from or had 
travelled to; (d) the patient would have been exposed to 
the bite of the vector which transmits P. knowlesi due to 
the nature of his occupation in the jungles of Malaysia; 
(e) chemoprophylaxis was not taken.
The natural macaque hosts of P. knowlesi, Macaca fas-
cicularis and Macaca nemestrina are not found in Sri 
Lanka [30]. It is therefore unlikely that onward trans-
mission of introduced or imported of P. knowlesi could 
occur or that the parasite could be maintained in the 
local monkey population. Thereby, any further onward 
transmission would have to be due to human to human 
transmission—which while experimentally proven to be 
possible [8], has not been demonstrated to occur natu-
rally.  In spite of extensive microscopical screening of 
close contacts, not finding any other person with a P. 
knowlesi infection also supports the fact that there is no 
human to human transmission.
The AMC rigorously implements malaria surveil-
lance activities to keep Sri Lanka ‘malaria- free’. Regu-
lar screening programmes are conducted by the AMC 
amongst high-risk groups, including armed forces per-
sonnel returning from United Nations peace keeping 
missions to mitigate the risk of re-introduction of the dis-
ease. An excellent intersectoral collaboration exists with 
the armed forces to ensure that any individual arriving 
from a malaria-endemic country is informed in advance 
to the AMC. This patient was not screened for malaria 
as he arrived independently. AMC examines more than 
a million blood smears each year. With a proficient cadre 
of adequately resourced public health experts, parasitolo-
gists, entomologists, and malariologists and a good work 
ethic framework, the AMC currently strives to maintain 
its collaboration with diverse partners, including the mil-
itary and professional medical associations to prevent a 
malaria resurgence in Sri Lanka.
Conclusions
Plasmodium knowlesi should be suspected in patients 
returning from countries in the South Asian region 
where the parasite is prevalent and when blood smear 
results are inconclusive. The mechanisms in place with 
regard to rapid response mounted by the AMC when an 
imported malaria case is reported, can be replicated in 
other countries attempting malaria elimination and pre-
venting re-introduction.
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